| Customization: | Available |
|---|---|
| Application: | Weight Loss |
| Disposable: | Non-Disposable |
| Quantity: | |
|---|---|
CAS 2381089-83-2
Retatrutide
CAS 2381089-83-2
| Appearance | White or off-white powder | |
| Solubility | Can be dissolved to 5mg/ml in pure water | |
| Molecular Ion Mass | 4731.42 ± 1 | |
| pH Value | 7.0 ~ 9.0 (C=5mg/ml) | |
| Water Content (K.F) | Not more than 8.0% | |
| Purity (HPLC) | Not less than 98.0% | |
| Related Substances (HPLC) | The largest individual impurity | Not more than 1.0% |
| The total impurities | Not more than 2.0% | |
| Residual Solvents (GC) | Methylene Chloride | Not more than 600ppm |
| Acetonitrile | Not more than 410ppm | |
| Methanol | Not more than 3000ppm | |
| N,N-Dimethylformamide | Not more than 880ppm | |
| Isopropyl ether | Not more than 5000ppm | |
| Bacterial Endotoxins | Not more than 10 EU/mg | |
| Microbial Limts | Total Aerobic Microbial Count | Not more than 1000 CFU/g |
| Total Combined Yeasts and Molds Count | Not more than 100 CFU/g | |
| Escherichia coli | Negative | |
| Salmonella | Negative | |
| Pseudomonas aeruginosa | Negative | |
| Staphylococcus aureus | Negative | |
| Product Codes | Product Names | Dosages |
| R5 | Retatrutide | 5mg*10vials |
| R10 | 10mg*10vials | |
| R15 | 15mg*10vials | |
| R20 | 20mg*10vials | |
| R30 | 30mg*10vials | |
| 2S10 | SS-31 | 10mg*10vials |
| 2S50 | 50mg*10vials | |
| MS10 | MOTS-c | 10mg*10vials |
| MS40 | 40mg*10vials | |
| TA5 | Thymosin Alpha-1 | 5mg*10vials |
| TA10 | 10mg*10vials | |
| MAZ5 | Mazdutide | 5mg*10vials |
| MAZ10 | 10mg*10vials | |
| CGL5 | Cagrilintide | 5mg*10vials |
| CGL10 | 10mg*10vials | |
| NJ100 | NAD+ | 100mg*10vials |
| NJ500 | 500mg*10vials | |
| DS5 | DSIP | 5mg*10vials |
| DS15 | 15mg*10vials |
